Response: Re: Dose escalation methods in phase i cancer clinical trials

Christophe Le Tourneau; J. Jack Lee; Lillian L. Siu

doi:10.1093/jnci/djp401

Response: Re: Dose escalation methods in phase i cancer clinical trials

Christophe Le Tourneau, J. Jack Lee, Lillian L. Siu

Biostatistics

Research output: Contribution to journal › Letter › peer-review

18 Scopus citations

Original language	English (US)
Pages (from-to)	1733-1735
Number of pages	3
Journal	Journal of the National Cancer Institute
Volume	101
Issue number	24
DOIs	https://doi.org/10.1093/jnci/djp401
State	Published - Dec 2009

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1093/jnci/djp401

Cite this

@article{8b5e605ca9364fff98b135b4c4264740,

title = "Response: Re: Dose escalation methods in phase i cancer clinical trials",

author = "{Le Tourneau}, Christophe and Lee, {J. Jack} and Siu, {Lillian L.}",

year = "2009",

month = dec,

doi = "10.1093/jnci/djp401",

language = "English (US)",

volume = "101",

pages = "1733--1735",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "24",

}

TY - JOUR

T1 - Response

T2 - Re: Dose escalation methods in phase i cancer clinical trials

AU - Le Tourneau, Christophe

AU - Lee, J. Jack

AU - Siu, Lillian L.

PY - 2009/12

Y1 - 2009/12

UR - http://www.scopus.com/inward/record.url?scp=72649100104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72649100104&partnerID=8YFLogxK

U2 - 10.1093/jnci/djp401

DO - 10.1093/jnci/djp401

M3 - Letter

AN - SCOPUS:72649100104

SN - 0027-8874

VL - 101

SP - 1733

EP - 1735

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 24

ER -

Response: Re: Dose escalation methods in phase i cancer clinical trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this